Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
17.08
+0.05 (0.29%)
At close: Nov 21, 2024, 4:00 PM
17.24
+0.16 (0.94%)
After-hours: Nov 21, 2024, 5:37 PM EST

Teva Pharmaceutical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
16,77215,84614,92515,87816,65916,887
Upgrade
Revenue Growth (YoY)
9.81%6.17%-6.00%-4.69%-1.35%-7.57%
Upgrade
Cost of Revenue
8,4138,2007,9528,2848,9339,351
Upgrade
Gross Profit
8,3597,6466,9737,5947,7267,536
Upgrade
Selling, General & Admin
3,6523,4983,4453,5283,6713,806
Upgrade
Research & Development
9789538389679971,010
Upgrade
Other Operating Expenses
-115282034
Upgrade
Operating Expenses
4,6294,4664,3114,5154,6714,820
Upgrade
Operating Income
3,7303,1802,6623,0793,0552,716
Upgrade
Interest Expense
-1,011-1,029-930-891-901-822
Upgrade
Interest & Investment Income
686810-10441
Upgrade
Earnings From Equity Investments
22219138-13
Upgrade
Currency Exchange Gain (Loss)
-43-3016-72615
Upgrade
Other Non Operating Income (Expenses)
-26-66-62-69-63-56
Upgrade
EBT Excluding Unusual Items
2,7202,1251,7172,1212,3591,881
Upgrade
Merger & Restructuring Charges
-70-111-146-133-120-199
Upgrade
Impairment of Goodwill
-1,000-700-2,045--4,628-
Upgrade
Gain (Loss) on Sale of Investments
----90--
Upgrade
Gain (Loss) on Sale of Assets
282864581949
Upgrade
Asset Writedown
-826-378-402-584-1,918-1,778
Upgrade
Legal Settlements
-667-1,038-2,069-698-60-1,173
Upgrade
Other Unusual Items
-713-548-261-781-59
Upgrade
Pretax Income
-528-622-3,142667-4,267-1,279
Upgrade
Income Tax Expense
689-7-643211-168-278
Upgrade
Earnings From Continuing Operations
-1,217-615-2,499456-4,099-1,001
Upgrade
Minority Interest in Earnings
2585653-391092
Upgrade
Net Income
-959-559-2,446417-3,990-999
Upgrade
Net Income to Common
-959-559-2,446417-3,990-999
Upgrade
Shares Outstanding (Basic)
1,1271,1191,1101,1021,0951,091
Upgrade
Shares Outstanding (Diluted)
1,1271,1191,1101,1071,0951,091
Upgrade
Shares Change (YoY)
0.87%0.81%0.27%1.10%0.37%6.86%
Upgrade
EPS (Basic)
-0.85-0.50-2.200.38-3.64-0.92
Upgrade
EPS (Diluted)
-0.86-0.50-2.200.38-3.64-0.92
Upgrade
Free Cash Flow
1,3688421,042236638223
Upgrade
Free Cash Flow Per Share
1.210.750.940.210.580.20
Upgrade
Gross Margin
49.84%48.25%46.72%47.83%46.38%44.63%
Upgrade
Operating Margin
22.24%20.07%17.84%19.39%18.34%16.08%
Upgrade
Profit Margin
-5.72%-3.53%-16.39%2.63%-23.95%-5.92%
Upgrade
Free Cash Flow Margin
8.16%5.31%6.98%1.49%3.83%1.32%
Upgrade
EBITDA
4,7864,3333,9704,4094,6124,438
Upgrade
EBITDA Margin
28.54%27.34%26.60%27.77%27.68%26.28%
Upgrade
D&A For EBITDA
1,0561,1531,3081,3301,5571,722
Upgrade
EBIT
3,7303,1802,6623,0793,0552,716
Upgrade
EBIT Margin
22.24%20.07%17.84%19.39%18.34%16.08%
Upgrade
Effective Tax Rate
---31.63%--
Upgrade
Advertising Expenses
-162168246225213
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.